|
|
|
Pharmaceutical
Hear more
To bring a new product to market – and to maintain quality after that product's release – pharmaceutical companies both large and small must balance many factors for success. Waters partners with organizations around the world to provide exactly the technologies and services that fully support your scientific and operational needs.
Whether that means optimizing your current laboratory output, or implementing a scalable and forward-looking solution that empowers you to achieve the innovation, productivity, and profitability goals that define your success, Waters works with you every step of the way.
Discover complete and specialized laboratory solutions for pharmaceutical companies that cross the entire pharmaceutical process: from sample preparation, chromatography, mass spectrometry, software, and informatics, to compliance, applications expertise, and support services.
With Waters LC/MS/MS systems for ADME screening, you can manage large sample loads with high capacity autosamplers, increase throughput with UPLC, and get the sensitivity needed with tandem quadrupole MS.
Waters solutions for bioanalysis are built on a logical workflow that combines UPLC, tandem quadrupole MS, and sample cleanup. This method development strategy enables analysts to efficiently address sensitivity, robustness, and regulatory challenges.
High-throughput compound library confirmation and purity screening is straightforward with UPLC technology.
The counterpart to Waters’ robust LC instrumentation for dissolution tests is software that eases system control and data collection.
Combine the chromatographic speed, resolution, and sensitivity of UPLC separations with the high-speed scan rates of photodiode array and MS detection will give you confidence that you are thoroughly identifying degradation products.
UPLC is a powerful tool for high-resolution identification and quantification of active pharmaceutical ingredients (APIs) and their related impurities.
To manufacture safe and effective drugs, labs critically analyze raw materials, process products, and final pharmaceutical products. Waters LC is used reliably in QA/QC labs to ensure purity and to measure stability over a drug’s intended shelf life.
For metabolite identification, UPLC and HDMS analytical technologies combine with the MetaboLynx Application Manager for a turnkey, high throughput analytical and reporting workflow solution for the drug development marketplace.
For metabonomics and metabolomics applications, the MarkerLynx Application Manager uses multivariate statistical methods to highlight compounds of interest, whether analyses use UPLC or GC with MS detection.
Labs are under pressure to improve analytical methods development processes that support tasks from scouting to stability testing. Waters' QbD-based technologies will radically upgrade your efficiency in method development.
Techniques such as purification and qualitative and quantitative chromatography and mass spectrometry are being applied to determine active drug candidates and to characterize the efficacy of traditional herbal medicines.
Walk-up open access systems enable chemists in drug discovery to analyze their own samples with easy-to-use software and UPLC or UPLC/MS.
|
|
|
Contact Waters
At APA 2010, Sept. 19-22 in Baltimore, talk with Waters about new solutions for bioanalysis & attend our mini symposium on Sunday.
See show info
Michael Balogh, a thought leader in small molecule applications at Waters, is a columnist for LC/GC.
Read his recent work.
It's simple to upgrade your lab.
|
|
